
How To Build Your Dream Life With AI
Living your dream life is more possible than ever before. You can be anyone you want to be, live wherever you want, set up the career that uses your superpowers and spend your time doing work that fills you up and hobbies you enjoy. The robots can handle the rest.
Award-winning entrepreneur Ngozi Elobuike knows this firsthand. The global AI strategist and founder transformed a moment of rock bottom (sleeping on her sister's couch) into a multi-country venture powered by AI. Now living across three countries (U.S., Ireland, and France) and pursuing her third master's degree, Ngozi has built Ireland's first black-led wine club, launched two premium beverage products, written an AI-powered travel book, and taught over 500 creatives how to use AI to unlock their potential. In her recent TEDx talk, that has already had over 200,000 views, Ngozi explains how to use today's tools to create a better tomorrow.
Most people stay stuck in lives they don't love because they think transformation takes years. They believe dream lives belong to other people. The lucky ones with connections, money, or special talents. But AI has demolished those barriers. When you give repetitive tasks to technology, you create space for what matters. Time to explore. Time to build. Time to become who you're meant to be.
I sold my social media agency in 2021 and used AI to build my next business. I learned to delegate everything that wasn't uniquely human to AI. I focus on doing the work I love: writing for Forbes, competing internationally in powerlifting, and living as a digital nomad across 35 cities.
The tools exist. The opportunity is here. You just need to start using them strategically instead of playing around. Stop treating ChatGPT like a toy and start building systems that free your time and amplify your strengths.
"What does a scientist do? They think about life as an experiment," says Elobuike. "You have dependent variables and you have independent variables. You have things that you can control in your settings." She calls AI an independent variable with the power to transform outcomes. "It actually has the ability to act as an enzyme. It has the ability to lower the activation energy needed to complete a task."
Start by auditing where your time actually goes. Track your days for a week. Note what drains you versus what energizes you. Identify the repetitive tasks eating your hours. Those are your first targets for AI automation. Use tools like Claude for writing, Zapier for workflows, or Perplexity for research. Each task you delegate creates space for activities that require your unique perspective and creativity.
Most people use AI for basic tasks when they could be accessing wisdom. "In the absence of an advisory board that has the ability to advise you on your business or the next step, how does AI slot in?" Elobuike asks. "Instead of asking your friend who may be a naysayer, 'hey, I'm thinking about starting this new idea venture', consider asking AI."
Create specialized AI advisors for different areas of your dream life. One for business strategy. Another for creative projects. A third for personal development. Give each specific context about your goals and challenges. "Prompt ChatGPT and say, I have an idea for X. Give me advice as if you were Oprah," suggests Elobuike. "This allows you to gain insight on things that you typically wouldn't have access to."
Most people never start because they think they need the perfect plan. But Elobuike advocates thinking like a consultant: "What consulting teaches you is to think about life as an experiment, but to think along the lines of ROI, return on investment, MVP, minimally viable product, and USP, unique selling point."
You don't need to quit your job tomorrow. Start with micro-experiments. Want to write? Use AI to help you publish one article. Dream of starting a business? Let AI help you validate your idea with market research. "If you want to test whether or not your audience will be interested in a new wine that you're presenting to them, the first step is not to create a wine," Elobuike explains. "The first step is to make a product mockup to see if the design that you've envisioned is something that your audience has an appetite for."
The numbers tell an interesting story. Around 32% of adults believe AI will benefit them, with younger adults and degree holders leading the optimism. Meanwhile, 36% remain sceptical, particularly women and older adults. This gap creates opportunity.
While others debate whether AI is good or bad, you can be building. Their hesitation is your head start. Use AI to maximize your natural talents while sceptics argue about hypotheticals. By the time they catch up, you'll have built the life they're still dreaming about.
"Growth hacking is what startup entrepreneurs created as a term back in 2010," notes Elobuike. "What is growth hacking? Imagine if you got not 1% better every day, but 10% better every day." You don't do this by becoming a robot. You do this by making intentional improvement in areas that matter to you.
Pick one aspect of your dream life. Maybe it's your morning routine, your creative output, or your business systems. Use AI to analyze what's working and what isn't. Test variations. Track results. "If you think about a system of continuous improvement, you thoroughly analyze each step in your user journey and think about how they can gain greater access to your product or service," Elobuike explains. Apply this thinking to your own life journey.
"Sparring is training," Elobuike reminds us. "You will not cut your teeth in your bedroom with your idea on a piece of paper, refusing to take action on it." The dream life you want won't build itself. But with AI as your partner, you can move faster than ever before.
Start today. Open ChatGPT and describe your dream life in detail. Ask it to help you identify the first three steps. Use AI to research, plan, and execute. Let it handle the mundane so you can focus on what makes you irreplaceable. Your dream life isn't a fantasy. It's a project waiting for you to begin.
Get my best ChatGPT prompts to change your life.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Hims & Hers Shares Plunge. Is This a Buying Opportunity or Should Investors Run for the Hills?
Key Points Hims & Hers Health continues to post robust growth. Shares sold off, however, after revenue missed analyst expectations. The stock is still reasonably valued given its growth prospects. 10 stocks we like better than Hims & Hers Health › Hims & Hers Health (NYSE: HIMS) is one of the most volatile stocks on the market at the moment, prone to big swings in either direction. This is true even intraday, as the stock plunged following the company's second-quarter results, only to rally back, only to plunge again. As of this writing, the stock is still trading up more than 130% this year. Let's take a closer look at the most recent earnings results for this telehealth company focused on providing accessible and affordable healthcare solutions for various health and wellness needs, and its prospects. Who knows, you might want to jump in on this somewhat volatile growth stock. Hims saw strong revenue growth in Q2 Hims & Hers continued to deliver outstanding revenue growth in Q2, with sales climbing 73% year over year to $544.8 million. That was toward the high end of its forecast for revenue of $530 million to $550 million, but it missed analyst expectations for revenue of $552 million. Monthly online revenue per subscriber jumped 30% to $74 per month, while the number of subscribers climbed 31% to nearly 2.44 million. The company said that the number of subscribers in both oral weight loss and dermatology grew more than 55% in the quarter. Customers using at least one personalized subscription increased by 89% to 1.5 million, representing more than 60% of the Hims & Hers subscriber base. It said that 70% of new patients who join the platform use a personalized treatment plan, and that the number of subscribers using a personalized treatment plan to treat multiple conditions skyrocketed 170% to more than 500,000. Revenue from GLP-1 weight loss drugs fell from $230 million in Q1 to $190 million in Q2, after Novo Nordisk ended a partnership with the telehealth company. Nonetheless, it still expects to generate $725 million of revenue this year from weight loss drugs, led by oral weight loss products and personalized doses. Hims & Hers continues to spend heavily on marketing to attract new customers. During the quarter, its marketing spending jumped 50% to nearly $218 million. Marketing expenses took up 40% of revenue in the quarter, though that was down from 46% a year ago, so the company continues to see leverage in this area despite the increased spending. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) surged to $82.2 million from $39.3 million a year ago. Adjusted earnings per share (EPS) came in at $0.17, topping the $0.15 analyst consensus as compiled by LSEG. Metric Q1 Results Growth (YOY) Revenue $544.8 million 73% Monthly online revenue per subscriber $74 30% Subscribers 2.44 million 31% Adjusted EBITDA $82.2 million 109% Adjusted EPS $0.17 183% Marketing expense $231 million 77% Marketing as % of revenue 40% (600 basis points) Gross margin 76% (500 basis points) Data source: Hims & Hers Health. YOY = year over year. Looking ahead, Hims & Hers maintained its forecast for 2025 revenue to be between $2.3 billion and $2.4 billion, equal to growth of 56% to 63%. It also kept its adjusted EBITDA guidance of $295 million to $335 million. For Q3, it projected revenue of between $570 million and $590 million, and adjusted EBITDA of $60 million to $70 million. The company is starting to look toward international expansion to bolster growth. It will begin by focusing on Canada next year, while its acquisition of Zava in July will help it expand into Europe. It also anticipates entering the Latin American and Asian markets in the coming years. Hims & Hers also continues to expand into new areas. It will launch hormonal health soon, starting with lab testing. The company believes this will help it reach its targets of $6.5 billion in revenue and $1.3 billion in adjusted EBITDA in 2030. Is the stock a buy? Hims & Hers continues to be a growth engine. Even though there's been some disruption from its spat with Novo Nordisk, it is still seeing strong growth across different health categories. With the company moving into new areas, like hormonal health and longevity, and looking to expand internationally, it has a lot of growth opportunities ahead. Meanwhile, with the majority of its subscribers on personalized treatment plans, it has a pretty sticky user base. From a valuation standpoint, the stock trades at a forward price-to-earnings (P/E) ratio of around 55 based on the analyst consensus for 2025. But its forward price/earnings-to-growth ratio (PEG) is under 0.6, and stocks with PEG ratios below 1 are usually considered undervalued. Given that it operates a subscription business with high gross margins, you can also look at the stock from a price-to-sales perspective; on that front, it trades at a multiple of 5.5 times 2025 analyst estimates. Overall, I'd say, based on the type of business the company is in, that it's still reasonably priced. However, it's still a volatile stock that carries some risk depending on what happens in the weight loss segment. Still, I really like its international opportunity, and think Hims & Hers Health could have solid long-term upside from here. Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Hims & Hers Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Geoffrey Seiler has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Hims & Hers Shares Plunge. Is This a Buying Opportunity or Should Investors Run for the Hills? was originally published by The Motley Fool 登入存取你的投資組合
Yahoo
6 minutes ago
- Yahoo
If You'd Invested $1,000 in Palantir Stock 3 Years Ago, Here's How Much You'd Have Today
Key Points Palantir's AIP contributed to accelerated revenue growth. Its growth has led to a pricey valuation, making its near-term direction less certain. 10 stocks we like better than Palantir Technologies › Palantir Technologies (NASDAQ: PLTR) stock has been on a tear since last year's U.S. presidential election. Since the election on Nov. 5, the stock is up by about 250%. While that is a considerable return, it is relatively modest compared to how the stock has performed over the last three years, when the market and Palantir were in the middle of a bear market. Amid the rising popularity of AI and its productivity solution, Palantir's returns since that time are nothing short of eye-popping. Palantir over the last three years If one had bought Palantir on Aug. 8, 2022, a $1,000 investment would be worth about $15,700 today. Three years ago, a dramatic pullback from the highs of the 2021 bull market left Palantir trading below $10 per share, the approximate level where it sold on its first day of trading on Sept. 30, 2020. Additionally, it got off to a slow start as it briefly fell below $6 per share in December 2022. Nonetheless, Palantir began moving higher in 2023, particularly after Open AI's release of an upgraded version of ChatGPT put the spotlight on generative AI. Palantir responded with its own generative AI solution, the artificial intelligence platform (AIP), in April 2023. Customers began reporting massive productivity gains. Over time, the stock's growth accelerated as revenue growth began to rise at a significantly faster rate. Consequently, the stock reached stratospheric highs, with a P/E ratio approaching 600. Although such earnings multiples can be common with growth stocks, its price-to-sales (P/S) ratio of 130 all but verifies that the market has priced the stock for perfection. That increases the odds of a dramatic fall at the slightest hint of bad news. However, few can deny the success of Palantir's investors over the last three years. Even if its near-term prospects are less clear, Palantir should succeed long term, since its tools have delivered massive productivity gains for its customers. Should you invest $1,000 in Palantir Technologies right now? Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Will Healy has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Palantir Technologies. The Motley Fool has a disclosure policy. If You'd Invested $1,000 in Palantir Stock 3 Years Ago, Here's How Much You'd Have Today was originally published by The Motley Fool
Yahoo
26 minutes ago
- Yahoo
Windows 11's New Mouse Options, Updated Settings App, and More: Windows Wednesday
Welcome back to Windows Wednesday, where we round up everything Microsoft rolled out in Windows over the past week. Here's everything that showed up across the Insider channels and release versions this week. You can join the Windows Insider program to try out experimental features, but some changes are on a gradual rollout and not yet available to all Insider program members. You should not install Windows Insider builds on an important computer. Input Microsoft was testing a new pointer indicator accessibility setting last year, and the feature has now returned in the Canary Channel. This adds red crosshairs to your cursor, so it's easier to find on a monitor. It can be enabled from Settings > Accessibility > Mouse pointer and touch > Pointer indicator, and afterwards it can be toggled with the Win+Ctrl+X keyboard shortcut. Microsoft said in a blog post, 'Low vision users on Windows can now easily locate and use their cursor. This will allow these users to be more productive and efficient when using a Windows device.' This reminds me of the virtual crosshairs found in some gaming monitors, but those are fixed to the center of the screen, while the Windows 11 feature moves with your mouse cursor. It's also a bit like the feature on macOS where the cursor will temporarily grow in size if you move it around quickly. Settings In the Dev Channel, Microsoft is removing the 'Manage or clear your Bing search history' option from Settings > Privacy & security > Search under Search history. You can still edit your Bing activity from the Privacy dashboard, linked in the Related settings on that settings page. The history page on the Bing website should also work the same way, as long as you're logged into the same Microsoft account as your PC. In the Canary Channel, the search box in Settings is moving to the top center of the window, which Microsoft says will 'deliver a more consistent and better search experience.' It was previously located in the left sidebar, under your profile picture and name. Microsoft already showed this off as part of the advanced Settings search on Copilot+ PCs, but now the updated design should appear on all PCs. File Explorer If your Windows PC is logged into a work or school account with Entra ID, the File Explorer already shows recently-changed files in the Home page. Now, Microsoft is adding user icons to that section, so you can more quickly recognize each person in the activity. This uses the person's Live Persona Card from the Microsoft 365 organizations. Home installations of Windows 11 still don't have these File Explorer features, but if you have a PC managed by your workplace or school, you might notice the new icons. This is rolling out in the Dev Channel. Source: Windows Insider Blog (1, 2, 3)